David Scadden - Jun 6, 2025 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
Director
Signature
/s/ David Scadden
Stock symbol
EDIT
Transactions as of
Jun 6, 2025
Transactions value $
$0
Form type
4
Date filed
6/10/2025, 04:19 PM
Previous filing
Dec 13, 2024
Next filing
Jun 23, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Scadden David Director C/O EDITAS MEDICINE, INC.,, 11 HURLEY ST., CAMBRIDGE /s/ David Scadden 2025-06-10 0001707715

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Award $0 +37.5K $0.00 37.5K Jun 6, 2025 Common Stock 37.5K $1.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026.